ADAGE CAPITAL PARTNERS GP LLC 13D and 13G filings for Travere Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-07 07:37 am Sale |
2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
ADAGE CAPITAL PARTNERS GP LLC | 500,000 0.670% |
-3,918,962 (-88.69%) |
Filing |
| 2023-03-13 4:30 pm Purchase |
2023-03-01 | 13G | Travere Therapeutics, Inc. TVTX |
ADAGE CAPITAL PARTNERS GP LLC | 4,418,962 5.940% |
1,818,962 (+69.96%) |
Filing |
| 2023-02-09 11:04 am Sale |
2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
ADAGE CAPITAL PARTNERS GP LLC | 2,600,000 4.050% |
-1,327,000 (-33.79%) |
Filing |
| 2022-10-28 4:30 pm Purchase |
2022-10-18 | 13G | Travere Therapeutics, Inc. TVTX |
ADAGE CAPITAL PARTNERS GP LLC | 3,927,000 6.140% |
2,624,508 (+201.50%) |
Filing |
| 2022-02-10 11:11 am Sale |
2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
ADAGE CAPITAL PARTNERS GP LLC | 1,302,492 2.130% |
-1,547,508 (-54.30%) |
Filing |
| 2021-01-04 4:05 pm Purchase |
2020-12-24 | 13G | Travere Therapeutics, Inc. TVTX |
ADAGE CAPITAL PARTNERS GP LLC | 2,850,000 5.580% |
2,850,000 (New Position) |
Filing |